American Century Companies Inc Repligen Corp Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Repligen Corp stock. As of the latest transaction made, American Century Companies Inc holds 287,401 shares of RGEN stock, worth $48.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

287,401

Previous 296,245 2.99%

Holding current value

$48.3 Million

Previous $37.3 Million 14.53%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $1.06 Million - $1.48 Million	-8,844 Reduced 2.99%	287,401 $42.8 Million
Q2 2024 Aug 07, 2024	SELL	$120.0 - $182.95 $24.4 Million - $37.2 Million	-203,328 Reduced 40.7%	296,245 $37.3 Million
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $22.5 Million - $27.4 Million	131,527 Added 35.74%	499,573 $91.9 Million
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $42 Million - $68.2 Million	368,046 New	368,046 $66.2 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $14.9 Million - $19 Million	107,570 Added 97.5%	217,900 $34.6 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $120,286 - $156,689	869 Added 0.79%	110,330 $15.6 Million
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $476,354 - $611,732	3,088 Added 2.9%	109,461 $18.4 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $3.21 Million - $4.36 Million	-19,766 Reduced 15.67%	106,373 $18 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $9.61 Million - $15.3 Million	-59,910 Reduced 32.2%	126,139 $23.6 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $48.5 Million - $64.8 Million	-344,479 Reduced 64.93%	186,049 $30.2 Million
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $13.3 Million - $21.3 Million	82,549 Added 18.43%	530,528 $99.8 Million
Q4 2021 Feb 07, 2022	BUY	$247.59 - $304.47 $1.32 Million - $1.63 Million	5,349 Added 1.21%	447,979 $119 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $7.67 Million - $12.8 Million	39,376 Added 9.76%	442,630 $128 Million
Q2 2021 Aug 05, 2021	SELL	$165.87 - $220.95 $7.7 Million - $10.3 Million	-46,403 Reduced 10.32%	403,254 $80.5 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $3.67 Million - $4.61 Million	-20,374 Reduced 4.33%	449,657 $87.4 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $3.21 Million - $4.48 Million	-21,667 Reduced 4.41%	470,031 $90.1 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $57.5 Million - $74.3 Million	469,434 Added 2108.49%	491,698 $72.5 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $2.1 Million - $3.13 Million	22,264 New	22,264 $2.75 Million
Q4 2017 Feb 02, 2018	SELL	$32.53 - $38.92 $1.67 Million - $2 Million	-51,400 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$36.98 - $46.06 $1.9 Million - $2.37 Million	51,400	51,400 $1.97 Million

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.1M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.32B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Repligen Corp Transaction History